23
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Bioprinting of Aptamer‐Based Programmable Bioinks to Modulate Multiscale Microvascular Morphogenesis in 4D

      research-article

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Dynamic growth factor presentation influences how individual endothelial cells assemble into complex vascular networks. Here, programmable bioinks are developed that facilitate dynamic vascular endothelial growth factor (VEGF) presentation to guide vascular morphogenesis within 3D‐bioprinted constructs. Aptamer's high affinity is leveraged for rapid VEGF sequestration in spatially confined regions and utilized aptamer‐complementary sequence (CS) hybridization to tune VEGF release kinetics temporally, days after bioprinting. It is shown that spatial resolution of programmable bioink, combined with CS‐triggered VEGF release, significantly influences the alignment, organization, and morphogenesis of microvascular networks in bioprinted constructs. The presence of aptamer‐tethered VEGF and the generation of instantaneous VEGF gradients upon CS‐triggering restricted hierarchical network formation to the printed aptamer regions at all spatial resolutions. Network properties improved as the spatial resolution decreased, with low‐resolution designs yielding the highest network properties. Specifically, CS‐treated low‐resolution designs exhibited significant vascular network remodeling, with an increase in vessel density(1.35‐fold), branching density(1.54‐fold), and average vessel length(2.19‐fold) compared to non‐treated samples. The results suggest that CS acts as an external trigger capable of inducing time‐controlled changes in network organization and alignment on‐demand within spatially localized regions of a bioprinted construct. It is envisioned that these programmable bioinks will open new opportunities for bioengineering functional, hierarchically self‐organized vascular networks within engineered tissues.

          Abstract

          Programmable bioinks are developed that dynamically control VEGF presentation by leveraging on aptamer's unique capabilities to specifically capture and release VEGF spatiotemporally within a bioprinted macroscale construct. It is shown that by using CS as an external trigger, aptamer‐CS hybridizes, releasing VEGF to modulate vascular network alignment and overall organization with temporal control, depending on bioink's spatial resolution.

          Related collections

          Author and article information

          Contributors
          j.rouwkema@utwente.nl
          Journal
          Adv Healthc Mater
          Adv Healthc Mater
          10.1002/(ISSN)2192-2659
          ADHM
          Advanced Healthcare Materials
          John Wiley and Sons Inc. (Hoboken )
          2192-2640
          2192-2659
          01 November 2024
          03 January 2025
          : 14
          : 1 ( doiID: 10.1002/adhm.v14.1 )
          : 2402302
          Affiliations
          [ 1 ] Department of Biomechanical Engineering Technical Medical Centre University of Twente Enschede 7522NB The Netherlands
          [ 2 ] Institute of Tissue Regeneration Engineering Dankook University Cheonan 31116 Republic of Korea
          [ 3 ] Department of Nanobiomedical Science and BK21 NBM Global Research Center for Regenerative Medicine Dankook University Cheonan 31116 Republic of Korea
          [ 4 ] Mechanobiology Dental Medicine Research Center Dankook University Cheonan 31116 Republic of Korea
          [ 5 ] UCL Eastman‐Korea Dental Medicine Innovation Centre Dankook University Cheonan 31116 Republic of Korea
          Author notes
          Author information
          https://orcid.org/0000-0002-0361-7036
          https://orcid.org/0009-0004-5496-6043
          https://orcid.org/0000-0002-4845-1519
          https://orcid.org/0000-0001-8309-0010
          https://orcid.org/0000-0001-9666-9064
          Article
          ADHM202402302
          10.1002/adhm.202402302
          11694088
          39487611
          e10357f8-45d1-48af-a03f-7bd818de52f3
          © 2024 The Author(s). Advanced Healthcare Materials published by Wiley‐VCH GmbH

          This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

          History
          : 17 October 2024
          : 24 June 2024
          Page count
          Figures: 9, Tables: 0, Pages: 21, Words: 14583
          Funding
          Funded by: HORIZON EUROPE European Research Council , doi 10.13039/100019180;
          Award ID: 101062032
          Categories
          Research Article
          Research Article
          Custom metadata
          2.0
          January 3, 2025
          Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.1 mode:remove_FC converted:02.01.2025

          3d‐bioprinting,aptamers,dynamic growth factors presentation,programmable bioinks,tissue engineering,vascular endothelial growth factor,vascularization

          Comments

          Comment on this article

          Related Documents Log